Traders purchased shares of CVS Health Corporation (NYSE:CVS) on weakness during trading on Thursday. $72.76 million flowed into the stock on the tick-up and $51.36 million flowed out of the stock on the tick-down, for a money net flow of $21.40 million into the stock. Of all equities tracked, CVS Health Corporation had the 18th highest net in-flow for the day. CVS Health Corporation traded down ($0.37) for the day and closed at $97.18

A number of equities analysts have recently weighed in on the company. Citigroup Inc. boosted their price target on CVS Health Corporation from $105.00 to $115.00 and gave the stock a “neutral” rating in a report on Monday, May 9th. Jefferies Group boosted their price target on CVS Health Corporation from $110.00 to $122.00 and gave the stock a “buy” rating in a report on Thursday, May 12th. Royal Bank Of Canada reissued an “outperform” rating and issued a $115.00 price target (up from $110.00) on shares of CVS Health Corporation in a report on Wednesday, May 4th. Mizuho reissued a “buy” rating and issued a $117.00 price target (up from $104.00) on shares of CVS Health Corporation in a report on Wednesday, May 4th. Finally, Leerink Swann reissued a “buy” rating and issued a $110.00 price target on shares of CVS Health Corporation in a report on Thursday, May 5th. Six investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. CVS Health Corporation currently has an average rating of “Buy” and a consensus target price of $113.02.

The company has a market capitalization of $103.61 billion and a P/E ratio of 22.36. The firm has a 50 day moving average of $96.28 and a 200 day moving average of $98.44.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $43.70 billion for the quarter, compared to the consensus estimate of $44.28 billion. The business’s revenue was up 17.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.19 earnings per share. On average, analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Thursday, July 21st were paid a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.75%. The ex-dividend date was Tuesday, July 19th.

Several large investors recently added to or reduced their stakes in CVS. Morgan Stanley raised its stake in CVS Health Corporation by 12.8% in the fourth quarter. Morgan Stanley now owns 11,485,756 shares of the pharmacy operator’s stock valued at $1,122,961,000 after buying an additional 1,304,751 shares in the last quarter. Vanguard Group Inc. raised its stake in CVS Health Corporation by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 68,950,833 shares of the pharmacy operator’s stock worth $6,741,323,000 after buying an additional 1,086,137 shares during the last quarter. BlackRock Advisors LLC raised its stake in CVS Health Corporation by 27.3% in the fourth quarter. BlackRock Advisors LLC now owns 4,896,947 shares of the pharmacy operator’s stock worth $478,774,000 after buying an additional 1,049,464 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in CVS Health Corporation by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,937,908 shares of the pharmacy operator’s stock worth $873,912,000 after buying an additional 689,609 shares during the last quarter. Finally, Wells Fargo & Company MN raised its stake in CVS Health Corporation by 3.1% in the fourth quarter. Wells Fargo & Company MN now owns 10,271,213 shares of the pharmacy operator’s stock worth $1,004,217,000 after buying an additional 313,389 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.